Epilepsy: Old Syndromes, New Genes
- 560 Downloads
Next-generation sequencing technologies have tremendously increased the speed of gene discovery in monogenic epilepsies, enabling us to identify a genetic cause in an increasing proportion of patients, and to better understand the underlying pathophysiology of their disease. The rapid speed with which new genes are being described lately, confronts clinicians with the difficult task of keeping up to date with the continuous supply of new publications. This article aims to discuss some of the genes that were recently discovered in monogenic familial epilepsy syndromes or epileptic encephalopathies for which an underlying cause remained unknown for a long time.
KeywordsEpilepsies Epileptic encephalopathies Genes Ion channels
Compliance with Ethics Guidelines
Conflict of Interest
Sarah Weckhuysen and Christian M. Korff declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 8.••Weckhuysen S, Mandelstam S, Suls A, Audenaert D, Deconinck T, Claes LRF, et al. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. Ann Neurol. 2012;71:15–25. This is the first of several publications on the role of KCNQ2 in 10 % of patients with neonatal EE.PubMedCrossRefGoogle Scholar
- 10.••Lemke JR, Lal D, Reinthaler EM, Steiner I, Nothnagel M, Alber M, et al. Mutations in GRIN2A predispose to idiopathic focal epilepsy with rolandic spikes. Nat Genet. 2013;45:1067–72. This article and the articles by Carvill et al.  and Lesca et al.  are three concomitantly published studies on the first major gene to be identified in childhood epilepsies of the rolandic spectrum.PubMedCrossRefGoogle Scholar
- 11.••Carvill GL, Regan BM, Yendle SC, O’Roak BJ, Lozovaya N, Bruneau N, et al. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet. 2013;45:1073–6. This article and the articles by Lemke et al.  and Lesca et al.  are three concomitantly published studies on the first major gene to be identified in childhood epilepsies of the rolandic spectrum.PubMedCrossRefGoogle Scholar
- 12.••Lesca G, Rudolf G, Bruneau N, Lozovaya N, Labalme A, Boutry-Kryza N, et al. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet. 2013;45:1061–6. This article and the articles by Lemke et al.  and Carvill et al.  are three concomitantly published studies on the first major gene to be identified in childhood epilepsies of the rolandic spectrum.PubMedCrossRefGoogle Scholar
- 21.Sugawara T, Tsurubuchi Y, Agarwala KL, Ito M, Fukuma G, Mazaki-Miyazaki E, et al. A missense mutation of the Na+ channel αII subunit gene Nav1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci U S A. 2001;98:6384–9.PubMedCentralPubMedCrossRefGoogle Scholar
- 44.••Barcia G, Fleming MR, Deligniere A, Gazula V-R, Brown MR, Langouet M, et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet. 2012;44:1255–9. This study was published simultaneously with that of Heron et al. . Both illustrate the phenotypic heterogeneity of mutations in the novel gene KCNT1.PubMedCentralPubMedCrossRefGoogle Scholar
- 45.••Heron SE, Smith KR, Bahlo M, Nobili L, Kahana E, Licchetta L, et al. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet. 2012;44:1188–90. This study was published simultaneously with that of Barcia et al. . Both illustrate the phenotypic heterogeneity of mutations in the novel gene KCNT1.PubMedCrossRefGoogle Scholar
- 58.•Suls A, Jaehn JA, Kecskés A, Weber Y, Weckhuysen S, Craiu DC, et al. De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome. Am J Hum Genet. 2013;93:967–75. In this era of big genome data science, animal models are becoming increasingly important to prove the pathogenicity of detected variants. This study generated a zebra fish model to prove the involvement of the gene CHD2 in epilepsy.PubMedCentralPubMedCrossRefGoogle Scholar
- 59.••Carvill GL, Heavin SB, Yendle SC, McMahon JM, O’Roak BJ, Cook J, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet. 2013;45(7):825–30. This article shows how the use of a targeted epilepsy panel in patients with EE can rapidly identify the underlying cause in 10 % of patients.PubMedCrossRefGoogle Scholar
- 60.••Epi4K Consortium. Epilepsy Phenome/Genome Project. De novo mutations in epileptic encephalopathies. Nature. 2013;501:217–21. This consortium study reports the results of trio exome sequencing in a cohort of 264 patients with infantile spasms or Lennox–Gastaut syndrome. The study illustrates the role of de novo mutations and the large genetic heterogeneity in EE.CrossRefGoogle Scholar
- 66.••Dibbens LM, de Vries B, Donatello S, Heron SE, Hodgson BL, Chintawar S, et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet. 2013;45:546–51. This article and the article by Ishida et al.  are two simultaneously published articles on the role of DEPDC5 focal epilepsies. This gene might become one of the more important genes to consider in the adult neurology practice where one is frequently confronted with patients with focal epilepsies of unknown origin.PubMedCrossRefGoogle Scholar
- 67.••Ishida S, Picard F, Rudolf G, Noé E, Achaz G, Thomas P, et al. Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat Genet. 2013;45:552–5. This article and the article by Dibbens et al.  are two simultaneously published articles on the role of DEPDC5 focal epilepsies. This gene might become one of the more important genes to consider in the adult neurology practice where one is frequently confronted with patients with focal epilepsies of unknown origin.PubMedCrossRefGoogle Scholar